NCT06226909 The Efficacy of Shear-wave Elastography-guided Biopsy for Diagnosis in Pleural Disease
| NCT ID | NCT06226909 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Pleural Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 234 participants |
| Start Date | 2024-01-15 |
| Primary Completion | 2027-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 234 participants in total. It began in 2024-01-15 with a primary completion date of 2027-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To investigate the information from shear-wave elastography on pleural tissues will improve the diagnosis of pleural diseases, as to increase the diagnostic yield in ultrasound-guided transthoracic pleura biopsy.
Eligibility Criteria
Inclusion Criteria: * Patients with radiographic evidence of pleural disease Exclusion Criteria: * Age \< 18 y/o * Patients who cannot hold their breath for 5 seconds
Contact & Investigator
Yao-Wen Kuo
PRINCIPAL INVESTIGATOR
National Taiwan University Hospital
Frequently Asked Questions
Who can join the NCT06226909 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pleural Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06226909 currently recruiting?
Yes, NCT06226909 is actively recruiting participants. Contact the research team at kyw@ntu.edu.tw for enrollment information.
Where is the NCT06226909 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT06226909 clinical trial?
NCT06226909 is sponsored by National Taiwan University Hospital. The principal investigator is Yao-Wen Kuo at National Taiwan University Hospital. The trial plans to enroll 234 participants.